Articles by Jim Miller - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Jim Miller

CMO Industry Thins Out

Oct 1, 2014

The trend of exits from the CMO industry looks to be gaining momentum.

Health Systems Raise the Bar on Reimbursing New Drugs

As payers refuse to cover new drugs, CMOs take a hit.
Jul 1, 2014

As payers refuse to cover new drugs, CMOs take a hit.

Stuck in Neutral

The CMO industry's value proposition is limiting its market penetration.
May 1, 2014

The CMO industry's value proposition is limiting its market penetration.

Under New Ownership

Changes in company ownership shake up the CMO industry.
Mar 1, 2014

Changes in company ownership shake up the CMO industry.

R&D in Transition

The R&D model is in transition and creating new demands on contract services providers.
Jan 1, 2014

The R&D model is in transition and creating new demands on contract services providers.

Climate Change in Outsourcing

Ongoing changes create new opportunities for CROs and CMOs.
Dec 1, 2013

Ongoing changes create new opportunities for CROs and CMOs.

The Expense of Vision in Outsourcing

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.
Oct 1, 2013

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.

Outsourcing Partnerships for CMC Development

Are strategic partnerships in clinical research a model for CMC services?
Sep 1, 2013

Are strategic partnerships in clinical research a model for CMC services?

Drug Approval Trends Don't Extend to CMOs

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.
Jun 1, 2013

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.

ADVERTISEMENT

ADVERTISEMENT

Click here